Growth Metrics

Iridex (IRIX) Net Income towards Common Stockholders (2010 - 2026)

Iridex's quarterly Net Income towards Common Stockholders came in at -$524000.0 in Q2 2026, up 68.92% year-on-year from -$310205.1 in Q2 2025, and up 38.64% quarter-over-quarter from -$854000.0 in Q1 2026.

Iridex has reported Net Income towards Common Stockholders for 17 years, with the latest figure at -$524000.0 in Q2 2026.

  • For the quarter ending Q2 2026, Net Income towards Common Stockholders rose 68.92% year-over-year to -$524000.0; the trailing twelve-month figure through Apr 2026 stood at -$3.9 million (down 354.52% YoY), and the FY2026 full-year result was -$5.1 million, down 2139.91% from the prior year.
  • Net Income towards Common Stockholders for Q2 2026 stood at -$524000.0, up from -$854000.0 in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was $7.8 million in Q4 2024, with the low at -$3.5 million in Q1 2024.
  • Average Net Income towards Common Stockholders over 5 years is -$691055.6, with a median of -$1.7 million recorded in 2023.
  • Year-over-year, Net Income towards Common Stockholders slumped 260.88% in 2022 and jumped 654.88% in 2023.
  • Tracing IRIX's Net Income towards Common Stockholders over 5 years: stood at -$1.2 million in 2022, then jumped by 654.88% to $6.7 million in 2023, then climbed by 16.89% to $7.8 million in 2024, then plunged by 120.04% to -$1.6 million in 2025, then surged by 66.69% to -$524000.0 in 2026.
  • The last three Net Income towards Common Stockholders figures came in at -$524000.0 (Q2 2026), -$854000.0 (Q1 2026), and -$1.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.08 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 745.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 187,319.30
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 199.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 411.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Iridex 18.87 Mn 14.27 Mn 4.74 Mn -524,000.00

Historic Data

Download Data 🔒
DateValue
Apr 4, 2026 -524,000.00
Jan 3, 2026 4.87 Mn
Sep 27, 2025 -1.57 Mn
Jun 28, 2025 -994,000.00
Mar 29, 2025 -1.69 Mn
Dec 28, 2024 7.85 Mn
Sep 28, 2024 -1.93 Mn
Jun 29, 2024 -2.68 Mn
Mar 30, 2024 -3.46 Mn
Dec 30, 2023 6.71 Mn
Sep 30, 2023 -1.75 Mn
Jul 1, 2023 -2.77 Mn
Apr 1, 2023 -2.09 Mn
Dec 31, 2022 -1.21 Mn
Oct 1, 2022 -1.77 Mn
Jul 2, 2022 -2.24 Mn
Apr 2, 2022 -2.39 Mn
Jan 1, 2022 6.16 Mn
Oct 2, 2021 -2.17 Mn
Jul 3, 2021 1.39 Mn
Apr 3, 2021 -2.01 Mn
Sep 26, 2020 -1.72 Mn
Jun 27, 2020 -2.78 Mn
Mar 28, 2020 -1.65 Mn
Dec 28, 2019 7.15 Mn
Sep 28, 2019 -1.79 Mn
Jun 29, 2019 -2.42 Mn
Mar 30, 2019 -3.05 Mn
Dec 29, 2018 9.82 Mn
Sep 29, 2018 -3.07 Mn
Jun 30, 2018 -3.28 Mn
Mar 31, 2018 -3.60 Mn
Dec 30, 2017 -5.16 Mn
Sep 30, 2017 -3.10 Mn
Jul 1, 2017 -2.75 Mn
Apr 1, 2017 -1.87 Mn
Dec 31, 2016 -10.82 Mn
Oct 1, 2016 -671,000.00
Jul 2, 2016 -328,000.00
Apr 2, 2016 101,000.00
Jan 2, 2016 -800,000.00
Oct 3, 2015 442,000.00
Jul 4, 2015 -652,000.00
Apr 4, 2015 246,000.00
Sep 27, 2014 490,000.00
Jun 28, 2014 297,000.00
Mar 29, 2014 487,000.00
Dec 28, 2013 412,000.00
Dec 29, 2012 2.29 Mn
Sep 29, 2012 -190,000.00
Mar 31, 2012 -162,000.00
Dec 31, 2011 169,000.00
Jul 2, 2011 39,000.00
Oct 2, 2010 910,000.00
Jul 3, 2010 814,000.00